BioSpace News Archive

Press Releases

Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases

February 17, 2026
·
7 min read
Press Releases

Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

February 17, 2026
·
3 min read
Press Releases

Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules

February 17, 2026
·
6 min read
Press Releases

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026

February 17, 2026
·
1 min read
Press Releases

Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 17, 2026
·
1 min read
Press Releases

Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 17, 2026
·
1 min read
Press Releases

ImmunityBio Reports Productive Regulatory Engagement with Saudi Food and Drug Authority at USA-Saudi Biotech Alliance Meeting Hosted by the Ministry of Investment of Saudi Arabia

February 17, 2026
·
18 min read
Press Releases

Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

February 17, 2026
·
18 min read
Press Releases

U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma

February 17, 2026
·
6 min read
Press Releases

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company’s Recently Initiated Strategic Transformation

February 17, 2026
·
7 min read